FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3678811000001102: Eryacne 2 gel (Galderma (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17565301000001113 Eryacne 2 gel (Galderma (UK) Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17565401000001117 Eryacne 2 gel (Galderma (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eryacne 2 gel (Galderma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Is a Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel true Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Has active ingredient Erythromycin false Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Is a Eryacne true Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Has specific active ingredient Erythromycin true Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Eryacne 2 gel (Galderma (UK) Ltd) 30 gram Is pack of False Eryacne 2 gel (Galderma (UK) Ltd) Inferred relationship Existential restriction modifier
Eryacne 2 gel (Galderma (UK) Ltd) 30 gram Has AMP True Eryacne 2 gel (Galderma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start